全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

The Impact of Socioeconomic Variables Status on Bladder Cancer Treatment Outcomes during the COVID-19 Pandemic

DOI: 10.4236/oalib.1107921, PP. 1-22

Subject Areas: Urology, Epidemiology, Economics, Sociology, Global Health

Keywords: Bladder Cancer, Complications, COVID-19, Public-Health, Socioeconomic Status, Treatment Outcomes

Full-Text   Cite this paper   Add to My Lib

Abstract

Social inequalities are concerning along the bladder cancer (BC) continuum especially within the malignancy outcomes and treatment effects and complications. Moreover, the COVID-19 crisis and its variants have uncovered major inequalities between communities and added more pressure on socioeconomic (SE) status along with the COVID-19-associated variants. Within this global situation, discerning the societal risk factors that render specific communities vulnerable is crucial to ensure more effective management of BC malignancy. In this paper, we aimed to investigate the status and the impact of SE variables and disparities on BC survival as reported in recent studies and give an update on the impact of social environment on treatment outcomes within COVID-19 pandemic. Several studies showed that SE status is a significant predictor of survival for BC patients. Recent evidence found that BC outcomes are directly affected by social deprivation. Our results confirm that there are major and recurrent SE disparities in BC survival. Together, the findings demonstrate the considerable impact in public data-based centers, albeit reportings are partial and inaccurate, of SE and health inequities in severely segregated neighborhoods under the weight of the COVID-19. The findings show the major influence of healthcare inequalities SE deprivation in a distinctly segregated community within the COVID-19 burden and death in centers according to public statistics, even if reports are unfinished and partial.

Cite this paper

Barki, C. , Rahmouni, H. B. and Labidi, S. (2021). The Impact of Socioeconomic Variables Status on Bladder Cancer Treatment Outcomes during the COVID-19 Pandemic. Open Access Library Journal, 8, e7921. doi: http://dx.doi.org/10.4236/oalib.1107921.

References

[1]  Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
[2]  Ferlay, J., Ervik, M., Lam, F., Colombet, M., Mery, L., Piñeros, M., Znaor, A., Soerjomataram, I. and Bray, F. (2018) Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer, Lyon.
[3]  Silvestri, G.A., Jemal, A., Yabroff, K.R., Fedewa, S. and Sineshaw, H. (2021) Cancer Outcomes among Medicare Beneficiaries and Their Younger Uninsured Counterparts: Study Compares Cancer Outcomes among Medicare Beneficiaries and Their Younger Uninsured Counterparts. Health Affairs, 40, 754-762. https://doi.org/10.1377/hlthaff.2020.01839
[4]  Erhunmwunsee, L., Seewaldt, V.L., Rebbeck, T.R. and Winn, R.A. (2021) From COVID-19 to Cancer, Watching Social Determinants Decide Life: When Will We Stop Spectating? Journal of the National Medical Association, 113, 436-439. https://doi.org/10.1016/j.jnma.2021.02.003
[5]  Spiess, P.E., Agarwal, N., Bangs, R., Boorjian, S.A., Buyyounouski, M.K., Clark, P.E. and Gurski, L.A. (2017) Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 15, 1240-1267. https://doi.org/10.6004/jnccn.2017.0156
[6]  Barki, C., Rahmouni, H.B. and Labidi, S. (2021) Prediction of Bladder Cancer Treatment Side Effects Using an Ontology-Based Reasoning for Enhanced Patient Health Safety. Informatics, 8, Article No. 55. https://doi.org/10.3390/informatics8030055
[7]  Wang, T., Liu, S., Joseph, T. and Lyou, Y. (2020) Managing Bladder Cancer Care during the COVID-19 Pandemic Using a Team-Based Approach. Journal of Clinical Medicine, 9, Article No. 1574. https://doi.org/10.3390/jcm9051574
[8]  Connor, M. J., Winkler, M., Miah, S., et al. (2020) COVID-19 Pandemic—Is Virtual Urology Clinic the Answer to Keeping the Cancer Pathway Moving? BJU International, 125, E3-E4. https://doi.org/10.1111/bju.15061
[9]  Hastings, K.G., Boothroyd, D.B., Kapphahn, K., Hu, J., Rehkopf, D.H., Cullen, M. R. and Palaniappan, L. (2018) Socioeconomic Differences in the Epidemiologic Transition from Heart Disease to Cancer as the Leading Cause of Death in the United States, 2003 to 2015: An Observational Study. Annals of Internal Medicine, 169, 836-844. https://doi.org/10.7326/M17-0796
[10]  Rodriguez-Acevedo, A. J., Green, A. C., Sinclair, C., van Deventer, E. and Gordon, L. G. (2020) Indoor Tanning Prevalence after the International Agency for Research on Cancer statement on Carcinogenicity of Artificial Tanning Devices: Systematic Review and Meta-Analysis. British Journal of Dermatology, 182, 849-859. https://doi.org/10.1111/bjd.18412
[11]  Sylvester R.J., van der Meijden A.P.M., Oosterlinck W., Witjes J.A., Bouffioux C., Denis L., Newling D.W.W. and Kurth K. (2006) Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials. European Urology, 49, 466-477. https://doi.org/10.1016/j.eururo.2005.12.031
[12]  Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A. and Bray, F. (2021) Cancer Statistics for the Year 2020: An Overview. International Journal of Cancer, 149, 778-789. https://doi.org/10.1002/ijc.33588
[13]  Okuyama, A. and Hori, M. (2021) Age-Specific Bladder Cancer Incidence Rate in the World. Japanese Journal of Clinical Oncology, 51, 511-512. https://doi.org/10.1093/jjco/hyab011
[14]  Teoh, J.Y.C., Huang, J., Ko, W.Y.K., Lok, V., Choi, P., Ng, C.F. and Wong, M.C.S. (2020) Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita. European Urology, 78, 893-906. https://doi.org/10.1016/j.eururo.2020.09.006
[15]  Chang, N.T., Chang, Y.H., Huang, Y.T. and Chen, S.C. (2021) Factors Associated with Refusal or Discontinuation of Treatment in Patients with Bladder Cancer: A Cohort Population-Based Study in Taiwan. International Journal of Environmental Research and Public Health, 18, Article No. 618. https://doi.org/10.3390/ijerph18020618
[16]  Hamann, M.I., León-Règagnon, V., Fernández, M.V. and González, C.E. (2020) First Record of the Genus Choledocystus (Trematoda: Plagiorchiidae) for Amphibians of the Chacoan Region in Argentina. Anais da Academia Brasileira de Ciências, 92, Article ID: e20180384. https://doi.org/10.1590/0001-3765202020180384
[17]  Ahmadi, M., Ranjbaran, H., Amiri, M.M., Nozari, J., Mirzajani, M.R., Azadbakht, M. and Hosseinimehr, S.J. (2012) Epidemiologic and Socioeconomic Status of Bladder Cancer in Mazandaran Province, Northern Iran. Asian Pacific Journal of Cancer Prevention, 13, 5053-5056. https://doi.org/10.7314/APJCP.2012.13.10.5053
[18]  Shackley, D.C. and Clarke, N.W. (2005) Impact of Socioeconomic Status on Bladder Cancer Outcome. Current Opinion in Urology, 15, 328-331. https://doi.org/10.1097/01.mou.0000174965.26439.d1
[19]  Yee, D.S., Ishill, N.M., Lowrance, W.T., Herr, H.W. and Elkin, E.B. (2011) Ethnic Differences in Bladder Cancer Survival. Urology, 78, 544-549. https://doi.org/10.1016/j.urology.2011.02.042
[20]  Haque, W., Lewis, G.D., Verma, V., Darcourt, J.G., Butler, E.B. and Teh, B.S. (2018) The Role of Adjuvant Chemotherapy in Locally Advanced Bladder Cancer. Acta Oncologica, 57, 509-515. https://doi.org/10.1080/0284186X.2017.1415461
[21]  Trawalter, S., Hoffman, K. and Palmer, L. (2020) Out of Place: Socioeconomic Status, Use of Public Space, and Belonging in Higher Education. Journal of Personality and Social Psychology, 120, 131-144. https://doi.org/10.1037/pspi0000248
[22]  Little, C., Alsen, M., Barlow, J., Naymagon, L., Tremblay, D., Genden, E. and van Gerwen, M. (2021) The Impact of Socioeconomic Status on the Clinical Outcomes of COVID-19; A Retrospective Cohort Study. Journal of Community Health, 46, 794-802. https://doi.org/10.1007/s10900-020-00944-3
[23]  Vinitha Vijayan, D., Puranik, M.P. and Sowmya, K.R. (2020) Social Deprivation and Oral Health: A Narrative Review. International Journal of Applied Dental Sciences, 6, 355-360. https://doi.org/10.22271/oral.2020.v6.i4f.1087
[24]  Townsend, P. (2020) 11 Objective and Subjective Deprivation. In: Townsend, P., Ed., Poverty in the United Kingdom, University of California Press, Berkeley, 413-431.
[25]  Patterson, R., Panter, J., Vamos, E.P., Cummins, S., Millett, C. and Laverty, A.A. (2020) Associations between Commute Mode and Cardiovascular Disease, Cancer, and All-Cause Mortality, and Cancer Incidence, Using Linked Census Data over 25 Years in England and Wales: A Cohort Study. The Lancet Planetary Health, 4, e186-e194. https://doi.org/10.1016/S2542-5196(20)30079-6
[26]  Karadimitriou, N., Maloutas, T. and Arapoglou, V.P. (2021) Multiple Deprivation and Urban Development in Athens, Greece: Spatial Trends and the Role of Access to Housing. Land, 10, Article No. 290. https://doi.org/10.3390/land10030290
[27]  Launoy, G., Launay, L., Bryère, J., Dejardin, O. and Guillaume, E. (2021) The European Deprivation Index: A Tool to Help Build an Evidence-Based Cancer Policy for Europe. In: Launoy, G., Zadnik, V. and Coleman, M.P., Eds., Social Environment and Cancer in Europe, Springer, Cham, 13-19. https://doi.org/10.1007/978-3-030-69329-9_3
[28]  Davis, L.E., Coburn, N.G., Hallet, J., Earle, C.C., Liu, Y., Myrehaug, S. and Mahar, A.L. (2020) Material Deprivation and Access to Cancer Care in a Universal Health Care System. Cancer, 126, 4545-4552. https://doi.org/10.1002/cncr.33107
[29]  Mata, M.D.S. and Costa, í.D.C.C. (2020) Composition of the Health Inequality Index Analyzed from the Inequalities in Mortality and Socioeconomic Conditions in a Brazilian State Capital. Ciência & Saúde Coletiva, 25, 1629-1640. https://doi.org/10.1590/1413-81232020255.33312019
[30]  De Boniface, J., Szulkin, R. and Johansson, A.L. (2021) Survival after Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status: A Swedish National 6-Year Follow-Up of 48,986 Women. JAMA Surgery, 156, 628-637. https://doi.org/10.1001/jamasurg.2021.1438
[31]  Henstenburg, J.M., Lieber, A.M., Boniello, A.J., Kerbel, Y.E. and Shah, M. (2020) Higher Complication Rates after Management of Lower Extremity Fractures in Lower Socioeconomic Classes: Are Risk Adjustment Models Necessary? Trauma. https://doi.org/10.1177%2F1460408620975693
[32]  Wang, A.L., Zhong, X. and Hurd, Y. (2020) Comorbidity and Sociodemographic Determinants in COVID-19 Mortality in an US Urban Healthcare System. medRxiv. (Preprint) https://doi.org/10.1101/2020.06.11.20128926
[33]  Abdel-Rahman, O. (2020) Prognostic Impact of Socioeconomic Status among Patients with Malignant Melanoma of the Skin: A Population-Based Study. Journal of Dermatological Treatment, 31, 571-575. https://doi.org/10.1080/09546634.2019.1657223
[34]  Kou, K., Dasgupta, P., Aitken, J.F. and Baade, P.D. (2020) Impact of Area-Level Socioeconomic Status and Accessibility to Treatment on Life Expectancy after a Cancer Diagnosis in Queensland, Australia. Cancer Epidemiology, 69, Article ID: 101803. https://doi.org/10.1016/j.canep.2020.101803
[35]  Kuhn, Y., Koscielny, A., Glowka, T., Hirner, A., Kalff, J.C. and Standop, J. (2010) Postresection Survival Outcomes of Pancreatic Cancer According to Demographic Factors and Socio-Economic Status. European Journal of Surgical Oncology, 36, 496-500. https://doi.org/10.1016/j.ejso.2009.08.006
[36]  Russell, B., Moss, C., Papa, S., Irshad, S., Ross, P., Spicer, J. and Van Hemelrijck, M. (2020) Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report from Guy’s Cancer Center in London. Frontiers in Oncology, 10, Article No. 1279. https://doi.org/10.3389/fonc.2020.01279
[37]  Luo, J., Kroenke, C.H., Hendryx, M., Shadyab, A.H., Liu, N., Chen, X. and Wactawski-Wende, J. (2021) Mediation Analysis of Racial Disparities in Triple-Negative Breast Cancer Incidence among Postmenopausal Women. Breast Cancer Research and Treatment, 188, 283-293. https://doi.org/10.1007/s10549-021-06158-y
[38]  Richiardi, L., Bellocco, R. and Zugna, D. (2013) Mediation Analysis in Epidemiology: Methods, Interpretation and Bias. International Journal of Epidemiology, 42, 1511-1519. https://doi.org/10.1093/ije/dyt127
[39]  Barki, C., Labidi, S. and Rahmouni, H.B. (2017) Ontology-Driven Generation of Radiation Protection Procedures. International Journal of Environmental, Chemical, Ecological, Geological and Geophysical Engineering, 11, 256-261.
[40]  Bryere, J., Dejardin, O., Launay, L., Colonna, M., Grosclaude, P. and Launoy, G. (2018) Socioeconomic Status and Site-Specific Cancer Incidence, a Bayesian Approach in a French Cancer Registries Network Study. European Journal of Cancer Prevention, 27, 391-398. https://doi.org/10.1097/CEJ.0000000000000326
[41]  Bryere, J., Tron, L., Menvielle, G. and Launoy, G. (2019) The Respective Parts of Incidence and Lethality in Socioeconomic Differences in Cancer Mortality. An Analysis of the French Network Cancer Registries (FRANCIM) Data. International Journal for Equity in Health, 18, Article No. 189. https://doi.org/10.1186/s12939-019-1087-y
[42]  Guy, L. (2019) Impact de l’intégration du test immunologique dans le programme de dépistage du cancer colorectal en France. Bulletin du Cancer, 106, 703-706. https://doi.org/10.1016/j.bulcan.2019.01.011
[43]  Fauvernier, M., Roche, L., Uhry, Z., Tron, L., Bossard, N. and Remontet, L. (2019) Challenges in the Estimation of Net Survival Working Survival Group. Multi-Dimensional Penalized Hazard Model with Continuous Covariates: Applications for Studying Trends and Social Inequalities in Cancer Survival. Journal of the Royal Statistical Society: Series C (Applied Statistics), 68, 1233-1257. https://doi.org/10.1111/rssc.12368
[44]  Assari, S., Khoshpouri, P. and Chalian, H. (2019) Combined Effects of Race and Socioeconomic Status on Cancer Beliefs, Cognitions, and Emotions. Healthcare, 7, Article No. 17. https://doi.org/10.3390/healthcare7010017
[45]  Kweon, S.S., Kim, M.G., Kang, M.R., Shin, M.H. and Choi, J.S. (2017) Diference of Stage at Cancer Diagnosis by Socioeconomic Status for Four Target Cancers of the National Cancer Screening Program in Korea: Results from the Gwangju and Jeonnam Cancer Registries. Journal of Epidemiology, 27, 299-304. https://doi.org/10.1016/j.je.2016.07.004
[46]  Sung, J.M., Martin, J.W., Jefferson, F.A., Sidhom, D.A., Piranviseh, K., Huang, M. and Youssef, R.F. (2019) Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry. Clinical Genitourinary Cancer, 17, 995-1002. https://doi.org/10.1016/j.clgc.2019.05.008
[47]  Mihor, A., Tomsic, S., Zagar, T., Lokar, K. and Zadnik, V. (2020) Socioeconomic Inequalities in Cancer Incidence in Europe: A Comprehensive Review of Population-Based Epidemiological Studies. Radiology and Oncology, 54, 1-13. https://doi.org/10.2478/raon-2020-0008
[48]  Golombos, D.M., O’Malley, P., Lewicki, P., Nguyen, D.P., Stone, B.V., Al Awamlh, B.A.H. and Scherr, D.S. (2017) The Impact of Socioeconomic Status on Perioperative Complications and Oncologic Outcomes in Patients Undergoing Radical Cystectomy. World Journal of Urology, 35, 1063-1071. https://doi.org/10.1007/s00345-016-1972-6
[49]  Barki, C., Rahmouni, H.B. and Labidi, S. (2021) Model-Based Prediction of Oncotherapy Risks and Side Effects in Bladder Cancer. Procedia Computer Science, 181, 818-826. https://doi.org/10.1016/j.procs.2021.01.235
[50]  Lee, H.E., Zaitsu, M., Kim, E.A. and Kawachi, I. (2020) Occupational Class and Cancer Survival in Korean Men: Follow-Up Study of Nation-Wide Working Population. International Journal of Environmental Research and Public Health, 17, Article No. 303. https://doi.org/10.3390/ijerph17010303
[51]  Stringhini, S., Sabia, S., Shipley, M., Brunner, E., Nabi, H., Kivimaki, M. and Singh-Manoux, A. (2010) Association of Socioeconomic Position with Health Behaviors and Mortality. JAMA, 303, 1159-1166. https://doi.org/10.1001/jama.2010.297
[52]  Mason, S.J., Downing, A., Wright, P., Hounsome, L., Bottomley, S.E., Corner, J. and Glaser, A.W. (2018) Health-Related Quality of Life after Treatment for Bladder Cancer in England. British Journal of Cancer, 118, 1518-1528. https://doi.org/10.1038/s41416-018-0084-z
[53]  Wong, M.C., Fung, F.D., Leung, C., Cheung, W.W., Goggins, W.B. and Ng, C.F. (2018) The Global Epidemiology of Bladder Cancer: A Joinpoint Regression Analysis of Its Incidence and Mortality Trends and Projection. Scientific Reports, 8, Article No. 1129. https://doi.org/10.1038/s41598-018-19199-z
[54]  Afshar, N., English, D.R., Blakely, T., Thursfield, V., Farrugia, H., Giles, G.G. and Milne, R.L. (2020) Differences in Cancer Survival by Area-Level Socio-Economic Disadvantage: A Population-Based Study Using Cancer Registry Data. PLoS ONE, 15, Article ID: 0228551. https://doi.org/10.1371/journal.pone.0228551
[55]  Cette, G., Lopez, J., Mairesse, J. and Nicoletti, G. (2020) Economic Adjustment during the Great Recession: The Role of Managerial Quality. Working Paper No. w27954, National Bureau of Economic Research, Cambridge. https://doi.org/10.3386/w27954
[56]  Mackenbach, J.P., Hu, Y., Artnik, B., Bopp, M., Costa, G., Kalediene, R. and Nusselder, W.J. (2017) Trends in inequalities in mortality amenable to health care in 17 European countries. Health Affairs, 36, 1110-1118. https://doi.org/10.1377/hlthaff.2016.1674
[57]  Singh, G.K., Kogan, M.D. and Slifkin, R.T. (2017) Widening Disparities in Infant Mortality and Life Expectancy between Appalachia and the Rest of the United States, 1990-2013. Health Affairs, 36, 1423-1432. https://doi.org/10.1377/hlthaff.2016.1571
[58]  Dickman, S.L., Himmelstein, D.U. and Woolhandler, S. (2017) Inequality and the health-Care System in the USA. The Lancet, 389, 1431-1441. https://doi.org/10.1016/S0140-6736(17)30398-7
[59]  Dutta, A. and Bandyopadhyay, S. (2019) Policy Intervention for Access to Medicine: Does It Work Similarly for Poor and Non-Poor? The International Journal of Health Planning and Management, 34, e557-e568. https://doi.org/10.1002/hpm.2671
[60]  Hansen, H., Schäfer, I., Porzelt, S., Kazek, A., Lühmann, D. and Scherer, M. (2020) Regional and Patient-Related Factors Influencing the Willingness to Use General Practitioners as Coordinators of the Treatment in Northern Germany—Results of a Cross-Sectional Observational Study. BMC Family Practice, 21, Article No. 110. https://doi.org/10.1186/s12875-020-01180-3
[61]  Singh, G.K. and Jemal, A. (2018) Socioeconomic Inequalities in Cancer Incidence and Mortality. In: The American Cancer Society, Ed., The American Cancer Society’s Principles of Oncology: Prevention to Survivorship, Wiley, Hoboken, 23-32. https://doi.org/10.1002/9781119468868.ch3
[62]  Feinglass, J., Wang, J.A., Ye, J., Tessier, R. and Kim, H. (2021) Hospital Care for Opioid use in Illinois, 2016-2019. The Journal of Behavioral Health Services & Research, 1-13. https://doi.org/10.1007/s11414-020-09748-8
[63]  Vanthomme, K., Vandenheede, H. and Hagedoorn, P. (2016) Socioeconomic Disparities in Lung Cancer Mortality in Belgian Men and Women (2001-2011): Does It Matter Who You Live with? BMC Public Health, 16, Article No. 493. https://doi.org/10.1186/s12889-016-3139-1
[64]  Siegel, R.L., Miller, K.D. and Jemal, A. (2020) Cancer Statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 7-30. https://doi.org/10.3322/caac.21590
[65]  Siegel, R.L., Jemal, A., Wender, R.C., Gansler, T., Ma, J. and Brawley, O.W. (2018) An Assessment of Progress in Cancer Control. CA: A Cancer Journal for Clinicians, 68, 329-339. https://doi.org/10.3322/caac.21460
[66]  Kehm, R.D., Spector, L.G., Poynter, J.N., Vock, D.M., Altekruse, S.F. and Osypuk, T.L. (2018) Does Socioeconomic Status Account for Racial and Ethnic Disparities in Childhood Cancer Survival? Cancer, 124, 4090-4097. https://doi.org/10.1002/cncr.31560
[67]  Withrow, D.R., Berrington de González, A., Spillane, S., Freedman, N.D., Best, A.F., Chen, Y. and Shiels, M.S. (2019) Trends in Mortality Due to Cancer in the United States by Age and County-Level Income, 1999-2015. JNCI: Journal of the National Cancer Institute, 111, 863-866. https://doi.org/10.1093/jnci/djz123
[68]  Cao, W., Chen, H.D., Yu, Y.W., Li, N. and Chen, W.Q. (2021) Changing Profiles of Cancer Burden Worldwide and in China: A Secondary Analysis of the Global Cancer Statistics 2020. Chinese Medical Journal, 134, 783-791. https://doi.org/10.1097/CM9.0000000000001474
[69]  Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A. and Bray, F. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinician, 71, 209-249. https://doi.org/10.3322/caac.21660
[70]  Lortet-Tieulent, J., Georges, D., Bray, F. and Vaccarella, S. (2020) Profiling Global Cancer Incidence and Mortality by Socioeconomic Development. International Journal of Cancer, 147, 3029-3036. https://doi.org/10.1002/ijc.33114
[71]  Alexeeff, S.E., Schaefer, C.A., Kvale, M.N., Shan, J., Blackburn, E.H., Risch, N. and Van Den Eeden, S.K. (2019) Telomere Length and Socioeconomic Status at Neighborhood and Individual Levels among 80,000 Adults in the Genetic Epidemiology Research on Adult Health and Aging cohort. Environmental Epidemiology, 3, Article No. e049. https://doi.org/10.1097/EE9.0000000000000049
[72]  Khan, R.J., Needham, B.L., Advani, S., Brown, K., Dagnall, C., Xu, R. and Davis, S.K. (2021) Association of Childhood Socioeconomic Status with Leukocyte Telomere Length among African Americans and the Mediating Role of Behavioral and Psychosocial Factors: Results from the GENE-FORECAST Study. Journal of Racial and Ethnic Health Disparities, 1-12. https://doi.org/10.1007/s40615-021-01040-5
[73]  Schmidt, A.L., Bakouny, Z., Bhalla, S., Steinharter, J.A., Tremblay, D.A., Awad, M.M. and Doroshow, D.B. (2020) Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study. Cancer Cell, 38, 769-770. https://doi.org/10.1016/j.ccell.2020.10.023
[74]  Saini, K.S., Tagliamento, M., Lambertini, M., McNally, R., Romano, M., Leone, M. and de Azambuja, E. (2020) Mortality in Patients with Cancer and Coronavirus Disease 2019: A Systematic Review and Pooled Analysis of 52 Studies. European Journal of Cancer, 139, 43-50. https://doi.org/10.1016/j.ejca.2020.08.011
[75]  Zaniboni, A., Ghidini, M., Grossi, F., Indini, A., Trevisan, F., Iaculli, A. and Petrelli, F. (2020) A Review of Clinical Practice Guidelines and Treatment Recommendations for Cancer Care in the COVID-19 Pandemic. Cancers, 12, Article No. 2452. https://doi.org/10.3390/cancers12092452
[76]  Singh, A.K., Singh, R., Joshi, S.R. and Misra, A. (2021) Mucormycosis in COVID-19: A Systematic Review of Cases Reported Worldwide and in India. Diabetes & Metabolic Syndrome. Clinical Research & Reviews, 15, Article ID: 102146. https://doi.org/10.1016/j.dsx.2021.05.019
[77]  Williams, H., Hutchinson, D. and Stone, H. (2021) Watching Brief: The Evolution and Impact of COVID-19 Variants B.1.1.7, B.1.351, P.1 and B.1.617. Global Biosecurity, 3, 1-127.
[78]  Ahmadikia, K., Hashemi, S.J., Khodavaisy, S., Getso, M.I., Alijani, N., Badali, H. and Rezaie, S. (2021) The Double-Edged Sword of Systemic Corticosteroid Therapy in Viral Pneumonia: A Case Report and Comparative Review of Influenza-Associated Mucormycosis versus COVID-19 Associated Mucormycosis. Mycoses, 64, 798-808. https://doi.org/10.1111/myc.13256
[79]  Rao, V., Arakeri, G., Subash, A., Ajaikumar, B.S., Patil, R., Hale, B. and Mendes, R.A. (2021) Decreased Cancer Consultations in the COVID-19 Era: A Concern for Delay in Early Cancer Diagnosis in India. JCO Global Oncology, 7, 408-409. https://doi.org/10.1200/GO.21.00030
[80]  Dai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z. and Cai, H. (2020) Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak. Cancer Discovery, 10, 783-791. https://doi.org/10.1158/2159-8290.CD-20-0422
[81]  Gordon, N.P. and Crouch, E. (2019) Digital Information Technology Use and Patient Preferences for Internet-Based Health Education Modalities: Cross-Sectional Survey Study of Middle-Aged and Older Adults with Chronic Health Conditions. JMIR Aging, 2, Article No. e12243. https://doi.org/10.2196/12243
[82]  Ware, P., Bartlett, S.J., Paré, G., Symeonidis, I., Tannenbaum, C., Bartlett, G. and Ahmed, S. (2017) Using eHealth Technologies: Interests, Preferences, and Concerns of Older Adults. Interactive Journal of Medical Research, 6, Article No. e3. https://doi.org/10.2196/ijmr.4447
[83]  Russell, B., Hemelrijck, M.V., Gårdmark, T., Holmberg, L., Kumar, P., Bellavia, A. and Häggström, C. (2020) A Mediation Analysis to Explain Socio-Economic Differences in Bladder Cancer Survival. Cancer Medicine, 9, 7477-7487. https://doi.org/10.1002/cam4.3418
[84]  Weiner, A.B., Keeter, M.K., Manjunath, A. and Meeks, J.J. (2018) Discrepancies in Staging, Treatment, and Delays to Treatment May Explain Disparities in Bladder Cancer Outcomes: An Update from the National Cancer Data Base (2004-2013). Urologic Oncology: Seminars and Original Investigations, 36, 237.e9-237.e17. https://doi.org/10.1016/j.urolonc.2017.12.015
[85]  Golombos, D.M., O’Malley, P., Lewicki, P., Nguyen, D.P., Stone, B.V., Al Awamlh, B.A.H. and Scherr, D.S. (2017) The Impact of Socioeconomic Status on Perioperative Complications and Oncologic Outcomes in Patients Undergoing Radical Cystectomy. World Journal of Urology, 35, 1063-1071. https://doi.org/10.1007/s00345-016-1972-6
[86]  Modi, P.K., Hollenbeck, B.K., Oerline, M., Weizer, A.Z., Montgomery, J.S., Kaffenberger, S.D. and Ellimoottil, C. (2019) Real-World Impact of Minimally Invasive versus Open Radical Cystectomy on Perioperative Outcomes and Spending. Urology, 125, 86-91. https://doi.org/10.1016/j.urology.2018.10.022
[87]  Azadeh, N.A., Ghodoussipour, S., Pearce, S., Bhanvadia, S. and Daneshmand, S. (2019) Socioeconomic and Insurance Status Are Independent Prognostic Indicators of Higher Disease Stage and Worse Prognosis in Bladder Cancer.b Urologic Oncology: Seminars and Original Investigations, 37, 784-790. https://doi.org/10.1016/j.urolonc.2019.04.021
[88]  Reis, L.O., Moro, J.C., Ribeiro, L.F., Voris, B.R. and Said, M.V. (2016) Are We Following the Guidelines on Non-Muscle Invasive Bladder Cancer? International braz j urol, 42, 22-28. https://doi.org/10.1590/S1677-5538.IBJU.2015.0122
[89]  Simon, S. (2019) FDA Approves Padcev (Enfortumab vedotin-ejfv) for Bladder Cancer. American Cancer Society, Atlanta.
[90]  US Food and Drug Administration (2020) FDA Approves Pembrolizumab for BCG-Unresponsive, High-Risk Non-Muscle Invasive Bladder Cancer. US Food and Drug Administration, Silver Spring.
[91]  Zlatev, D.V., Altobelli, E.L. and Joseph C. (2015) Advances in Imaging Technologies in the Evaluation of High-Grade Bladder Cancer. Urologic Clinics, 42, 147-157. https://doi.org/10.1016/j.ucl.2015.01.001
[92]  Decerf, B., Ferreira, F.H., Mahler, D. and Sterck, O. (2020) Lives and Livelihoods: Estimates of the Global Mortality and Poverty Effects of the Covid-19 Pandemic. Policy Research Working Paper, 9277, 1-37. https://doi.org/10.1596/1813-9450-9277
[93]  ElKadhi, Z., Elsabbagh, D., Frija, A., Lakoud, T., Wiebelt, M. and Breisinger, C. (2020) The Impact of Covid-19 on Tunisia’s Economy, Agri-Food System, and Households. No. 5, International Food Policy Research Institute (IFPRI), Washington DC. https://doi.org/10.2499/p15738coll2.133737
[94]  Mohamed, A. (2021) A Literature Review: The Impact of COVID-19 Pandemic on Somaliland Economy. Open Journal of Social Sciences, 9, 54-64. https://doi.org/10.4236/jss.2021.92004

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413